117 related articles for article (PubMed ID: 32602464)
1. Prognostic Significance of Circulating CD28 Negative Suppressor T Cells and Memory B Cells in Patients with Breast Cancer.
Zahran AM; Shaltout AS; Fakhry H; Khallaf SM; Abdel Fattah ON; Temerik DF; Rayan A
Iran J Immunol; 2020 Jun; 17(2):95-110. PubMed ID: 32602464
[TBL] [Abstract][Full Text] [Related]
2. Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.
Song G; Wang X; Jia J; Yuan Y; Wan F; Zhou X; Yang H; Ren J; Gu J; Lyerly HK
Cancer Immunol Immunother; 2013 Jun; 62(6):1123-30. PubMed ID: 23604172
[TBL] [Abstract][Full Text] [Related]
3. CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer.
Vahidi Y; Bagheri M; Ghaderi A; Faghih Z
BMC Cancer; 2020 Mar; 20(1):257. PubMed ID: 32228503
[TBL] [Abstract][Full Text] [Related]
4. Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
Bailur JK; Gueckel B; Derhovanessian E; Pawelec G
Breast Cancer Res; 2015 Mar; 17(1):34. PubMed ID: 25849846
[TBL] [Abstract][Full Text] [Related]
5. Circulating CD8
Song Q; Ren J; Zhou X; Wang X; Song G; Hobeika A; Yuan Y; Lyerly HK
Cytotherapy; 2018 Jan; 20(1):126-133. PubMed ID: 28988693
[TBL] [Abstract][Full Text] [Related]
6. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
[TBL] [Abstract][Full Text] [Related]
8. Decreased level of peripheral CD8
Li Y; Qian T; Zhao H; Zhang Z; Ming Y; Qiao G; Liu J
Future Oncol; 2020 Nov; 16(32):2611-2617. PubMed ID: 32820651
[No Abstract] [Full Text] [Related]
9. The clinical implication of CD45RA
Hang J; Huang J; Zhou S; Wu L; Zhu Y; Zhu L; Zhou H; Xu K; Jiang H; Yang X
Cancer Med; 2019 Mar; 8(3):1326-1335. PubMed ID: 30767430
[TBL] [Abstract][Full Text] [Related]
10. Loss of CD28 within CD4
Escarra-Senmarti M; Bueno-Topete MR; Jave-Suarez LF; Gomez-Bañuelos E; Gutierrez-Franco J; Vega-Magaña N; Aguilar-Lemarroy A; Pereira-Suarez AL; Haramati J; Del Toro-Arreola S
Immunol Lett; 2017 Feb; 182():30-38. PubMed ID: 28087292
[TBL] [Abstract][Full Text] [Related]
11. Variable Abnormalities in T and B Cell Subsets in Ataxia Telangiectasia.
Moeini Shad T; Yousefi B; Amirifar P; Delavari S; Rae W; Kokhaei P; Abolhassani H; Aghamohammadi A; Yazdani R
J Clin Immunol; 2021 Jan; 41(1):76-88. PubMed ID: 33052516
[TBL] [Abstract][Full Text] [Related]
12. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
13. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
[TBL] [Abstract][Full Text] [Related]
15. Changes in the number of CD80(+), CD86(+), and CD28(+) peripheral blood lymphocytes have prognostic value in melanoma patients.
Martínez-Escribano JA; Hernández-Caselles T; Campillo JA; Campos M; Frías JF; García-Alonso A; Alvarez-López MR
Hum Immunol; 2003 Aug; 64(8):796-801. PubMed ID: 12878358
[TBL] [Abstract][Full Text] [Related]
16. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
Speiser DE; Valmori D; Rimoldi D; Pittet MJ; Liénard D; Cerundolo V; MacDonald HR; Cerottini JC; Romero P
Eur J Immunol; 1999 Jun; 29(6):1990-9. PubMed ID: 10382762
[TBL] [Abstract][Full Text] [Related]
17. T-cell dynamics during acute SIV infection.
Mattapallil JJ; Letvin NL; Roederer M
AIDS; 2004 Jan; 18(1):13-23. PubMed ID: 15090825
[TBL] [Abstract][Full Text] [Related]
18. CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells.
Fiorentini S; Licenziati S; Alessandri G; Castelli F; Caligaris S; Bonafede M; Grassi M; Garrafa E; Balsari A; Turano A; Caruso A
J Immunol; 2001 Jan; 166(2):900-7. PubMed ID: 11145666
[TBL] [Abstract][Full Text] [Related]
19. Immune modulation during treatment of systemic sclerosis with plasmapheresis and immunosuppressive drugs.
Dau PC; Callahan JP
Clin Immunol Immunopathol; 1994 Feb; 70(2):159-65. PubMed ID: 8299231
[TBL] [Abstract][Full Text] [Related]
20. Functional and phenotypic characterization of CD8+CD28+ and CD28- T cells in atopic individuals sensitized to Dermatophagoides pteronyssinus.
Lourenço O; Fonseca AM; Paiva A; Arosa FA; Taborda-Barata L
Allergol Immunopathol (Madr); 2006; 34(6):234-41. PubMed ID: 17173839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
